UNSPSC 51142550: Ciladopa hydrochloride

This classification denotes a dopamine agonist with the molecular formula C21H26N2O4.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ASR1NR721I. The term ciladopa hydrochloride is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule ciladopa hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, CILADOPA HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: COC1CCC(CC1OC)[C@@H](CN2CCN(CC2)C3CCCCCC3=O)O.CL.

UNSPSC 51142550 Ciladopa hydrochloride is a Commodity code with minimal recent state and local procurement activity. The single identified opportunity—Seminole County, Florida's IFB for Naloxone and Drug Deactivation Systems—does not align with the code's nominal scope of ciladopa hydrochloride, a pharmaceutical compound. The mismatch suggests either miscoding of the county's solicitation or limited actual procurement under this specific commodity code within state and local government contracting. Ciladopa hydrochloride procurement, if it occurs in the state and local sector, does not appear in the recent opportunities reviewed.

Without representative solicitations directly matching this code's pharmaceutical scope, no reliable characterization of issuing-body mix, geographic concentration, or typical contract terms can be drawn from current market activity. The code shows no actionable recent opportunity for business development purposes.